| Registry | NCT04753385, acronym UNCOVER |
|---|---|
| Status | Terminated - UNCOVER terminated early based on low enrollment and lack of device data collected making analysis unfeasible. |
| Study type | Observational |
| Enrollment | 138 (Actual) |
| Sponsor | LivaNova (Industry) |
| Conditions | Treatment Resistant Depression |
| Dates | start 2021-03-23, primary completion 2024-09-06, completion 2024-09-06, first posted 2021-02-15, last updated 2024-12-20 |
| Locations | 33 sites in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Treatment Resistant Depression
The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).
A prospective, observational, exploratory study collecting passive and active behavioral, environmental and physiological data, via the use of an Android smartphone application and Study Watch.
This sub-study is only open to sites participating in the RECOVER clinical study.
All subjects participating in the RECOVER clinical trial at active UNCOVER sites will be offered participation in this sub-study.
Subjects who opt-in to the Mood App portion of the sub-study will be followed for a minimum of 12 months and a maximum of 60 months for the Mood App portion of the sub-study.
Subjects who opt-in to the use of the Study Watch portion of the sub-study will be followed for a minimum of 12 months and maximum of 24 months for the Study Watch portion of the sub-study.
Sex: All, ages: 18 Years to any
Inclusion Criteria: All Subjects 1. Current consented subject in the RECOVER clinical trial; 2. Adult (i.e. ≥ 18 years of age, unless a resident of any U.S. state where the age of majority is 19, in which case must be ≥ 19 years of age); 3. Able and willing to provide written informed consent for this sub-study; 4. Able and willing to comply with all study procedures; 5. Able to read and speak English. Phone Application 1. Have a personal Google user account or be willing to create and own a personal Google user account; 2. Owns a personal Android smartphone with a data plan and is the sole user of that smartphone; 3. Agrees to download and maintain the phone application onto personal Android smartphone for the duration of the sub-study; Study Watch 1\. Willing to comply with Study Watch wearing and recharging requirements Exclusion Criteria: All Subjects 1\. Any condition or situation the Principal Investigator determines as inappropriate for study inclusion Phone Application No additional exclusion criteria for phone application Study Watch 1\. Subjects with known severe allergy to nickel or metal jewelry
| Facility | City | Country | Status |
|---|---|---|---|
| University of Alabama at Birmingham | Birmingham, Alabama | United States | |
| ATP Clinical Research, Inc. | Costa Mesa, California | United States | |
| Keck Hospital of USC | Los Angeles, California | United States | |
| SF-Care, Inc. | San Rafael, California | United States | |
| Kind Research Group | Boca Raton, Florida | United States | |
| APG Research, LLC | Orlando, Florida | United States | |
| Nova Psychiatry Inc. | Orlando, Florida | United States | |
| Advanced Mental Health Care Inc. | Royal Palm Beach, Florida | United States | |
| Florida Center for TMS | Saint Augustine, Florida | United States | |
| Stedman Clinical Trials | Tampa, Florida | United States | |
| Augusta University | Augusta, Georgia | United States | |
| AMR-Baber Research, Inc. | Naperville, Illinois | United States | |
| Psychiatric Medicine Associates, LLC | Skokie, Illinois | United States | |
| Southern Illinois University School of Medicine | Springfield, Illinois | United States | |
| Beacon Medical Group Behavioral Health | South Bend, Indiana | United States | |
| Sheppard Pratt Health Systems | Baltimore, Maryland | United States | |
| Michigan Clinical Research Institute PC | Ann Arbor, Michigan | United States | |
| Psychiatric Care and Research | O'Fallon, Missouri | United States | |
| PsychCare Consultants Research | St Louis, Missouri | United States | |
| Alivation Research, LLC | Lincoln, Nebraska | United States | |
| Hapworth Research Inc. | New York, New York | United States | |
| Center for Neuropsychiatry and Brain Stimulation (CNBS) | Cary, North Carolina | United States | |
| Ohio State University | Columbus, Ohio | United States | |
| OU-SOCM Dept of Psychiatry | Tulsa, Oklahoma | United States | |
| Scranton Medical Institutes | Moosic, Pennsylvania | United States | |
| University of Pennsylvania Perelman School of Medicine | Philadelphia, Pennsylvania | United States | |
| UT Health Austin | Austin, Texas | United States | |
| UT Center of Excellence on Mood Disorders | Houston, Texas | United States | |
| North Pointe Psychiatry | Lewisville, Texas | United States | |
| Neuropsychiatric Associates, Plc | Woodstock, Vermont | United States | |
| Carilion Clinic | Roanoke, Virginia | United States | |
| Seattle Neuropsychiatric Treatment Center | Bellevue, Washington | United States | |
| Center for Anxiety and Depression | Mercer Island, Washington | United States |